Journals / Türk Kardiyoloji Derneği Arşivi / 2002 / Cilt: 30 - Sayı: 10

Cardiac complications after chemoterapy: Report of two cases

Kemoterapi sonrası gelişen kardiyak komplikasyonlar: İki olgu sunumu

Pages
654–657
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The patient who received 5-fluorouracil for a colon cancer was diagnosed as coronary artery vasospasm, and the other patient who received cyclophosphamid and cisplatin for an ovarian cancer was considered to have nonfatal toxic myocarditis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The cardiac complications of chemotherapeutic agents are increasing with more common usage of chemotherapy protocols.
📊
Key Findings & Data:In this report, we described 2 patients who had chest pain and electrocardiographical changes after chemotherapy.
💡
Conclusion & Impact:The patient who received 5-fluorouracil for a colon cancer was diagnosed as coronary artery vasospasm, and the other patient who received cyclophosphamid and cisplatin for an ovarian cancer was considered to have nonfatal toxic myocarditis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The cardiac complications of chemotherapeutic agents are increasing with more common usage of chemotherapy protocols. In this report, we described 2 patients who had chest pain and electrocardiographical changes after chemotherapy. Both patients had normal coronary angiography. The patient who received 5-fluorouracil for a colon cancer was diagnosed as coronary artery vasospasm, and the other patient who received cyclophosphamid and cisplatin for an ovarian cancer was considered to have nonfatal toxic myocarditis.

Özet

Kemoterapi uygulamalarının ve protokollerinin artması kardiyak komplikasyonların daha sık görülmesine neden olmuştur. Bu makalede kemoterapi sonrası göğüs ağrısı ve elektrokardiyografi değişiklikleriyle kardiyoloji kliniğimizde izleme alınan iki ayrı olgu ele alınmıştır. Her ikisinin de koroner arterleri anjiyografik olarak normal bulunan olgularımızda; kolon karsinomu nedeniyle 5-Fluorouracil kullanımı sonrası vazospastik angina pektoris ve over karsinomu nedeniyle siklofosfamid+cisplatin tedavisi sonrası fatal olmayan toksik miyokardit tanıları konuldu.

🔖

Cite This Article

AKBULUT, T., TERZİ, S., BİLSEL, T., SAYAR, N., OĞUZ, E., DAYİ, Ü. Ş. (2022). Cardiac complications after chemoterapy: Report of two cases. Türk Kardiyoloji Derneği Arşivi, Cilt: 30 - Sayı: 10, 654–657. https://ajindex.com/articles/633955

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Brestescher C, Patuier P, Farge D: Chemotherapy and cardiotoxicity. Ann Cardiol Angiol 1995; 44:443-7 2. Tutku A, İnanlı S, Caymaz O, Ayanoğlu E, Duman D: Cardiotoxicity of 5-Fluorouracil: two case reports. Auris Nasus Larynx 2001; 28:193-6. 3. Porta C, Moroni M, Ferrari S, Nastasi G: Endothelin-1 and 5-fluorouracil-induced cardiotoxicity. Neoplasma 1998; 45:81-2 4. Cwikiel M, Eskilsson J, Albertsson M, Stavenow L: The influence of 5-fluorouracil and methotrexate on vascular endothelium. An experimental study using endothelial cells in the culture. Ann Oncol 1996; 7:731-7 5. Prunier F, Monsequ J, Coutant G, Ollivier JP: Emergency coronary angioplasty following treatment with 5-fluorouracil. Rev Med Interne 2000; 21:439-44 6. Miura Y, Ueda M, Kondou Y, et al: Sudden cardiac tamponad due to hemorrhagic myocarditis after preconditioning marrow transplantation with cyclophosphamide in a patient with aplastic anemia. Rinsho Ketsueki 1997; 38:526-31 7. Birchall IW, Lalani Z, Venner P, Hugh J: Fatal haemorrhagic myocarditis secondary to cyclophosphamide therapy. Br J Radiol 2000; 73:1112-4 8. Morandi P, Ruffini PA, Benvenuto GM, et al: Serum cardiac troponin I levels and ECG/Echo monitoring in breast cancer patients undergoing high-dose (7g/m2) cyclophosphamide. Bone Marrow Transplant 2001; 28:277-82 9. Federman DG, Henry G: Chemotherapy-induced myocardial necrosis in a patient with chronic lymphocytic leukemia. Respir Med 1997; 91:565-7 10. Berliner S, Rahima M, Sidi Y, et al: Acute coronary events following cisplatin-based chemotherapy. Cancer Invest 1990; 8:583-6 11. Gerl A: Vascular toxicity associated with chemotherapy for testicular cancer. Anticancer Drugs 1994; 5:607-14 12. Fukuda M, Oka M, Itoh N, et al: Vasospastic angina likely related to cisplatin-containing chemotherapy and thoracic irradiation for lung cancer. Intern Med 1999; 38:436-8 13. Rodriguez J, Collazos J, Gallardo M, Hernando G: Angina pectoris following cisplatin, etoposide and bleomycin in a patient with advanced testicular cancer. Ann Pharmacother 1995; 29:138-9 14. Fisch C: Electrocardiography. The ECG and electrolyte abnormalites. Braunwald E (ed). Heart Disease. Philedelphia, WB Saunders Company, 1997; p.141-2